50 filings analyzed. Top movers: Catalyst Bancorp, Inc., CID Holdco, Inc., SOUNDTHINKING, INC., SurgePays, Inc., Global Business Travel Group, Inc..
8-K/A
Catalyst Bancorp, Inc.
Catalyst Bancorp completed acquisition of Lakeside Bancshares for $19.58/share ($41.1M total cash) on July 14, 2026. Lakeside had $385.7M assets, $287.5M deposits, and $36.1M equity as of Dec 31, 2025. Pro forma combined company had $625.3M assets and $3.4M goodwill.
▲ Likely positive
· significance 95 · 8-K Agent
8-K
CID Holdco, Inc.
CID Holdco (market cap $7.2M) agreed on September 25, 2026 to acquire 100% of Envoy Technologies, Inc. from BladeRanger Ltd. (which owns 135 shares, 100% pre-conversion). Consideration: 10,833,333 shares valued at $65M ($6/share reference price)—233,543 common shares and 8,433,123 Series C Preferred shares to BladeRanger; 2,166,667 Series C Preferred to a convertible noteholder (subject to joinder). Series C converts post-shareholder approval, subject to 19.99% blocker. Envoy holds a $12.5M convertible note convertible to 20% equity pre-closing.
▲ Likely positive
· significance 92 · 8-K Agent
8-K
SurgePays, Inc.
SurgePays, Inc. filed an 8-K on September 29, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing indicates the company has failed to meet continued listing requirements; specific reasons, counterparties, dollar amounts, and remediation details are not disclosed in the accessible portions of this filing.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
Global Business Travel Group, Inc.
Long Lake Management completed its all-cash acquisition of Global Business Travel Group, Inc. (Amex GBT) on September 29, 2026, for approximately $6.3 billion, or $9.50 per share—a 65.1% premium to the 30-day volume-weighted average price as of the May 4, 2026 announcement date. The transaction was approved by stockholders on August 3, 2026. Amex GBT common stock has ceased trading on the NYSE and will be delisted; the company now operates as a privately held subsidiary of Long Lake. The deal was financed through Long Lake investor equity, Koch Equity Development LLC equity, and committed debt financing.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
BEST SPAC I Acquisition Corp.
BEST SPAC I Acquisition Corp. (market cap ~$55.2M) filed an 8-K on September 29, 2026 reporting a change of control under Item 5.01. The filing does not disclose the identity of the acquiring party, transaction consideration, deal terms, financing details, closing conditions, or timing. No financial statements or material agreements are attached. The filing appears incomplete or substantive details are withheld.
— Neutral
· significance 92 · 8-K Agent
8-K
GEN Restaurant Group, Inc.
GEN Restaurant Group (market cap ~$21K) entered into a Common Stock Purchase Agreement dated September 29, 2026 with Roth Principal Investments, LLC. The deal grants Roth the right to purchase up to $25 million in Class A common stock (or 6,776,399 shares, whichever is less, subject to stockholder approval and Exchange Cap limits) at market prices via multiple daily purchase windows. Roth receives a $500,000 commitment fee (payable via 10% withholding from purchase prices) and reimbursement of legal fees ($100K initial + $7,500/quarter). The company reserved 15 million shares and must maintain an effective registration statement for resales.
▲ Likely positive
· significance 92 · 8-K Agent
SCHEDULE 13D/A
Aterian, Inc.
David Elliot Lazar, Aterian director and major shareholder, is selling 706,100 Series AA Preferred Shares and 1,750,000 Series AAA Preferred Shares (convertible into 241.9M common shares, ~92.5% fully diluted) to 19 named offshore purchasers for $12M gross ($11.75M cash at close, $250K indemnity holdback). Michelle Chiam Sin Ling acts as Purchaser Representative. Placement agent fee: $240K (2.0%). Closing scheduled September 18, 2026. One Purchaser-designated director will join the board; one existing director (non-Seller) will resign.
▼ Likely negative
· significance 92 · Ownership Agent
8-K
Immix Biopharma, Inc.
Immix announced interim Phase 2 results for NXC-201 (CAR-T therapy) in relapsed/refractory AL Amyloidosis across 45 patients: 89% complete response rate (40/45), with all 25 new patients either in CR or MRD-negative; 4 additional MRD-negative patients could push CR rate to 98% (44/45) if confirmed. No relapses, neurotoxicity, or enterocolitis observed. Final readout and BLA submission planned mid-2027.
▲ Likely positive
· significance 78 · 8-K Agent
8-K
Host Digital Inc.
Host Digital Inc. (market cap ~$11.4M) completed a merger bringing a data center platform into the public company formerly known as Healthy Choice Wellness. The company signed a 15-year take-or-pay lease at its first facility (Site I) in northeast Oklahoma with ~$1.25 billion in contracted base-term rent ($67M annually, 3% escalators), covering 55 MW gross/43 MW IT capacity. The company raised $17.5M gross in its recent public offering and has invested ~$40M to date; it targets Q1 2027 delivery and is pursuing project-level financing. The Sponsor (privately held Host Infrastructure Holdings, controlled by CEO Harmol Samra and founders) holds a pipeline of 450+ MW across four additional sites potentially deliverable by end-2027, and has preferential rights to contribute projects to Host under negotiated terms, typically receiving Host shares as payment.
▲ Likely positive
· significance 78 · 8-K Agent
8-K
Capstone Holding Corp.
Capstone Holding Corp. retired approximately $5.82 million of its original $6.82 million convertible note principal, reducing remaining convertible debt to $1 million as of September 29, 2026. The company fully retired the July 2025 convertible note and reduced the October 2025 note balance from $1.9 million (as of June 30, 2026) to $1 million through conversions. Q2 2026 showed strong operational performance: revenue increased 67% YoY to $21.5 million, gross profit rose 92% to $6.0 million, and gross margin expanded 357 basis points to 27.9%.
▲ Likely positive
· significance 78 · 8-K Agent
8-K
Maison Solutions Inc.
On September 23, 2026, Maison Solutions Inc. received a Nasdaq notification stating the company is non-compliant with Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for Q3 FY2026 (ended July 31, 2026) and its Form 10-K for FY2026 (ended April 30, 2026). The company has until October 19, 2026 to submit a compliance plan to Nasdaq; if accepted, it receives until February 9, 2027 to file both reports. No immediate delisting action; stock continues trading on Nasdaq Capital Market under symbol MSS.
▼ Likely negative
· significance 78 · 8-K Agent
8-K
Scilex Holding Co
On September 25, 2026, Scilex Holding Company (as Holder) and Vivasor, Inc. (as Company) amended a promissory note originally issued August 8, 2026. The maximum credit amount increased from $20,000,000 to $30,000,000 — a $10M increase. No other terms of the underlying note were modified.
— Neutral
· significance 78 · 8-K Agent
8-K
Super League Enterprise, Inc.
Super League Enterprise established an at-the-market (ATM) offering program on August 18, 2026, through sales agents The Benchmark Company and StoneX Financial to sell up to $5,465,000 of common stock. The program was registered via Form S-3 (effective December 20, 2024) with prospectus supplements dated August 21, 2026 and September 29, 2026. This is a standard legal opinion letter confirming the shares' valid issuance under Delaware law.
▼ Likely negative
· significance 78 · 8-K Agent
8-K
Silicon Valley Acquisition Corp.
Silicon Valley Acquisition Corp. (SVAQ, ~$220M assets) and EigenQ Inc. publicly filed an S-4 registration statement on September 28, 2026 for their proposed business combination. EigenQ separately secured approximately $45 million in convertible financing (half already funded) to support commercialization. Post-closing, SVAQ will domesticate to Delaware, rename to EigenQ Holdings Inc., and trade on Nasdaq under tickers EIGQ (common) and EIGQW (warrants). Closing is expected in Q4 2026, subject to SEC effectiveness, shareholder approvals, and listing requirements.
▲ Likely positive
· significance 78 · 8-K Agent
SCHEDULE 13D
PMGC Holdings Inc.
PMGC Holdings Inc. acquired 100% membership interest in NorthStrive Sponsor I LLC from Manager Georgiy Kovalyov for $1.00, effective April 24, 2026. The LLC holds 2,728,070 Class A ordinary shares of NorthStrive Acquisition Corp I (a blank-check SPAC that completed its IPO on August 19, 2026), comprising 2,496,320 shares underlying convertible Class B shares and 231,750 shares from private placement. PMGC now controls the sponsor vehicle for a potential SPAC business combination.
— Neutral
· significance 78 · Ownership Agent
4
ADARx Pharmaceuticals, Inc.
10% owner SR ONE CAPITAL MANAGEMENT, LLC (ADRX) bought 9.9M shares (~$27.2M) on the open market (94% of holdings). Open-market insider purchase — historically a bullish signal.
▲ Likely positive
· significance 78 · Insider Agent
8-K
URANIUM ENERGY CORP
Uranium Energy Corp reported fiscal 2026 results showing Q4 production of 82,744 pounds (up 157% from Q3), with total cash cost per pound of $30.01 and total cost per pound of $36.54. Full-year fiscal 2026 production totaled 229,294 pounds at $34.24 cash cost per pound. The company sold 400,000 pounds at weighted average realized price of $93.13/lb, generating $37.3M revenue and $16.9M gross profit. Key catalysts: Burke Hollow (first full mine to start production in U.S. in 10+ years) produced 17,352 pounds in first quarter; Christensen Ranch production doubled to 65,392 pounds with cost per pound down 35%; balance sheet shows $753M liquid assets (including $495M cash) with zero debt; NNSA indicated need for 4M pounds/year unobligated U.S.-origin uranium by 2030; subsidiary URC advancing uranium conversion facility toward Class IV cost estimate by mid-2027.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics raised full-year 2026 revenue guidance from $350–370M to $410–420M (midpoint +$55M, ~15% increase), driven by strong U.S. demand for Amtagvi (lifileucel) and Proleukin. The company reported record Q2 2026 product revenue of $99.3M and expanded its authorized treatment center network to ~100 centers with plans for ≥110 by year-end 2026; the raised guidance implies ~60% annual revenue growth.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
JELD-WEN Holding, Inc.
JELD-WEN secured commitment from 94.5% of 2027 Notes holders (4.875% Senior Notes) and 72.2% of 2028 Term Loan lenders to extend maturities to 2031 and raise $135M new debt. The refinancing addresses near-term maturity wall, extends runway through 2031, and provides liquidity to support execution of operational transformation (cost reduction, footprint rationalization) and cyclical housing recovery. Exchange offers to all noteholders/lenders expected in coming weeks.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Unicycive Therapeutics, Inc.
Unicycive resubmitted its NDA for oxylanthanum carbonate on September 29, 2026, adding a new third-party drug product manufacturing vendor with FDA-approved facility status (No Action Indicated inspection, March 2024) and 12 months of stability data. The company expects FDA acceptance within 30 days and a new PDUFA date 6 months from resubmission. Cash position of $61.4M (as of June 30, 2026) supports runway into 2H 2027; the original vendor remains under FDA inspection assignment but uninspected as of filing date.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Imunon, Inc.
On September 28, 2026, Imunon, Inc. exchanged $1.2M of a $2.72M Secured Promissory Note (originally issued June 2, 2026 to Streeterville Capital, LLC) for 120 shares of newly designated Series B Preferred Stock with a stated value of $12,000/share ($1.44M total). The Series B stock carries 8% annual preferred return (15% upon default), is senior to common stock, requires majority Series B holder consent for future capital actions, and restricts the company from various material transactions without investor approval.
▼ Likely negative
· significance 72 · 8-K Agent
8-K
Moleculin Biotech, Inc.
Moleculin Biotech completed enrollment of 89 subjects in Part A of its pivotal MIRACLE Phase 2/3 trial evaluating Annamycin plus cytarabine for relapsed/refractory AML. The company remains on track for comprehensive Part A data readout in Q1 2027. Part A population is expected to be approximately 50/50 split between 'fit' (1L 7+3) and 'unfit' (venetoclax-based) subjects, compared to 70/30 in the first 45 enrolled; blinded data continues to show absence of cardiotoxicity.
▲ Likely positive
· significance 72 · 8-K Agent
SCHEDULE 13D
People Inc
HighSage Ventures LLC and Jennifer Stier, substantial multi-year shareholders in both People Inc (PPLI) and MGM Resorts, filed a joint Schedule 13D on 09/29/2026 expressing support for MGM's potential acquisition of PPLI. The letter proposes MGM could offer NAV in cash/stock (capped at 67M shares) to acquire PPLI's 67M MGM shares (~27% of MGM outstanding), arguing PPLI trades at $40/share while its MGM stake alone worth ~$45/share, and that a transaction would unlock persistent holding-company discount and allow PPLI shareholders to monetize or spin off the People publishing business.
▲ Likely positive
· significance 72 · Ownership Agent
8-K
Tessera Defense & Homeland Security Inc.
Tessera Defense (market cap ~$11.9M) announced 2027 revenue guidance of $14–16 million, comprised of $7M from backlog/contracts, $5M from existing customer expansion, and $3M from new customers. Management targets $21M in 2028 and $30M in 2029, implying 40% CAGR through 2029. Targets assume execution of platform deployments (70 sites), 60 new customers, 15 expansion projects, entry into 3 new geographies, 2 new verticals, and future unspecified acquisitions.
— Neutral
· significance 72 · 8-K Agent
8-K
Cadrenal Therapeutics, Inc.
Cadrenal's Board approved Amendment No. 2 to its 2022 Successor Equity Incentive Plan on September 24, 2026, increasing the maximum share reserve available for grants by 323,542 shares to a new total of 1,000,000 shares (from ~676,458 shares previously). The amendment also sets the Incentive Stock Option limit at 1,000,000 shares. Amendment is effective upon stockholder approval, which is required under applicable law.
— Neutral
· significance 72 · 8-K Agent
8-K
Harvard Ave Acquisition Corp
Harvard Ave Acquisition Corp (SPAC, ~$149.5M assets) entered a binding business combination agreement dated September 25, 2026 with OAG International Ltd and newly-formed holding company PubCo to merge. The deal values OAG at $300M (Exchange Ratio = $300M / $10/share / outstanding Company shares). Two-step merger: Merger Sub I merges into Acquiror (becoming PubCo subsidiary); then Merger Sub II merges into OAG. At closing, Acquiror shareholders receive PubCo shares; OAG shareholders receive PubCo shares at Exchange Ratio. Trust Account holds ~$149.8M as of Sept 21, 2026. Shareholders of both parties must approve; Company shareholders have already signed support agreement (requisite majority committed).
▲ Likely positive
· significance 72 · 8-K Agent
8-K
CION Investment Corp
CION Investment Corp repaid $114.8M Israel Series A Notes (at par plus accrued interest on Aug 31, 2026) and $200M JPMorgan Credit Facility advances (Sept 25, 2026), releasing all security interests. Simultaneously, on Sept 17, 2026, CION closed a joint venture with institutional investors (Senior Loan Fund Partners, LLC) capitalized with $125M senior secured notes and $59.7M equity, which acquired a $180.3M par portfolio of 20 first lien loans from CION at 99.8% of par. Pro-forma net leverage decreased to 1.35x as of June 30, 2026.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
BuzzFeed, Inc.
Allen Family Digital, LLC (controlled by Byron Allen) agreed to purchase 4,300,000 newly issued Class A shares of BuzzFeed at $1.09 per share for a total of $4.687M on September 23, 2026. The transaction provides BuzzFeed with ~$4.7M in cash capital. Allen receives registration rights and demand registration within 60 days; BuzzFeed retains ability to suspend registration twice yearly for up to 90 days each.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Vulcan Infrastructure & Power Inc.
Vulcan Infrastructure & Power Inc. entered into an Exchange Agreement (effective September 23, 2026) whereby holders of its 8.50% Senior Notes due October 31, 2026 (GREEL, CUSIP 39531G209) exchange those notes for: (1) an equal principal amount of 10.00% Senior Notes due June 30, 2030 (issued under a new indenture dated July 21, 2025), plus accrued interest from July 31, 2026; and (2) Class A Common Stock Purchase Warrants exercisable for shares at $1.87 per share with a 3-year term. The specific principal amounts, share counts, and warrant terms for each holder are identified on individual Holder Signature Pages (blanked in this template filing). The exchange is intended to be exempt from registration under Section 3(a)(9) of the Securities Act. Closing occurs by October 1, 2026. Holders receive piggyback registration rights for warrant shares and are subject to a 4.99% beneficial ownership cap and short-sale restrictions.
— Neutral
· significance 72 · 8-K Agent
8-K
MongoDB, Inc.
At September 29, 2026 investor day, MongoDB announced FY27 guidance of $2.99–$3.03B revenue (21–23% growth), with Atlas ARR growth ~27% YoY and EA Other ~11% YoY. Company launched MongoDB 9.0 GA (2x throughput vs. v8.0), Atlas Infinite (decoupled compute/storage, 96%+ faster scaling), and Atlas Agent Engine (public preview; agentic infrastructure with governance). Customer count reached 70,600 (+18% YoY); $1M+ customers grew 17% to 434. Non-GAAP operating margin expected ~21% (+250 bps YoY); FCF conversion 108%. Dev Ittycheria is interim CEO; leadership transition underway.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Aterian, Inc.
Aterian offered CEO David Lazar a $150,000 retention bonus ($75,000 on Sept 30, 2026 and $75,000 upon Q3 10-Q filing) to remain through Q3 2026 filing. Separately, the company declared a Contingent Value Rights cash distribution of approximately $0.9936 per CVR to holders of record as of July 8, 2026, payable on or about October 2, 2026, arising from asset sales completed July 17, 2026 to Trademark Global, LLC.
— Neutral
· significance 72 · 8-K Agent
8-K
Cboe Global Markets, Inc.
Cboe Global Markets and S&P Dow Jones Indices signed a 25-year extension of their exclusive licensing agreement on September 28, 2026, continuing Cboe's exclusive rights to list and trade S&P 500 index (SPX) options through December 31, 2051. The Master License Agreement supersedes prior agreements and covers standardized options, futures, and volatility-related shared IP indices (VIX, BXM, variance indicators). Cboe estimates 2027 royalty fee changes will have de minimis impact on net revenue growth, with future adjustments expected to be smaller than the 2027 reset; no impact on 2026 terms.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Stewards, Inc.
Stewards, Inc. (OTC: SWRD) agreed to purchase 100% membership interests in two entities owning a mixed-use Pompano Beach property (Envy Pompano Beach) for $90M. Purchase price: $1.5M deposit (satisfied by prior loans), ~$44.6M existing debt assumption, ~$43.9M in Stewards common stock ($3/share: ~14.6M shares at closing plus 7M escrowed shares at $3/share=$21M), and LoanCore loan ~$47.5M. Sellers (Envy Development PB LLC, The Myelin Group LLC, and individual owners) to receive required monthly $3M redemption payments starting October 2026 for escrowed shares; $5.5M annual liquidated damages (up to $33M total) if Issuer delists from Nasdaq. Closing targeted September 23, 2026.
▲ Likely positive
· significance 71 · 8-K Agent
8-K
INTERGROUP CORP
InterGroup Corporation reported fiscal 2026 GAAP net income of $0.336 million versus a net loss of $7.547 million in fiscal 2025 (swing of $7.883 million). Total revenues increased 15% to $73.951 million; Hotel Operations segment income rose 43% to $12.524 million driven by higher average daily rates ($253 vs. $218), occupancy (95% vs. 92%), and RevPAR ($239 vs. $200). The company also realized a $3.508 million gain on sale of a 12-unit multifamily property in December 2025 for $4.85 million. EBITDA increased 63% to $22.834 million. Portsmouth hotel's $67.0 million senior mortgage and $36.3 million mezzanine loan mature April 9, 2027, with management expecting to exercise the first one-year extension option.
▲ Likely positive
· significance 68 · 8-K Agent
8-K
Legacy Education Inc.
Legacy Education Inc. (LGCY, $101.1M market cap) reported fiscal year 2026 ended June 30, 2026: revenue $80.1M (+24.8% YoY from $64.2M), net income $9.1M (+21.3% from $7.5M), diluted EPS $0.66 (+11.9% from $0.59). Student population grew 8.9% to 3,377; new student starts increased 9.0% to 3,483. Company expanded capacity at California campuses, signed lease for first Houston, Texas campus, and secured approval for three new programs at Contra Costa Medical Career College.
▲ Likely positive
· significance 68 · 8-K Agent
8-K
Dyne Therapeutics, Inc.
Dyne Therapeutics announced additional one-year data from the ACHIEVE Phase 1/2 trial of z-basivarsen (DYNE-101) for myotonic dystrophy type 1. A pooled dose group (N=26) showed sustained functional improvement across multiple measures at 12 months versus baseline and versus placebo; vHOT (video hand opening time) improved 3.2 seconds at 6 months (vs. +0.4 sec placebo), 5xSTS improved 1.2 seconds, 10MWR improved 0.3 seconds, QMT total improved 4.8% predicted, and MDHI total score improved 25.2% relative to baseline. The company expects registrational expansion cohort (REC, N=71) topline data in Q1 2027 to support potential U.S. Accelerated Approval application in Q3 2027; REC mean baseline vHOT is 8.3 seconds. Safety profile remained favorable with no serious drug-related adverse events.
▲ Likely positive
· significance 68 · 8-K Agent
8-K
Concentrix Corp
Concentrix recorded a $1.05B non-cash goodwill impairment charge in Q3 2026 (ended Aug 31) due to depressed stock price and market capitalization, reducing reported operating income to -$910M vs. +$147M prior year. Excluding the impairment, non-GAAP operating income grew 1.3% to $309M and adjusted free cash flow reached record $218M. The board raised the quarterly dividend from $0.36 to $0.37 per share (effective Nov 3, 2026). Full-year guidance shows constant-currency revenue decline of 0.3%-0.8% and non-GAAP EPS of $10.97–$11.09 on ~61.1M diluted shares.
▼ Likely negative
· significance 68 · 8-K Agent
8-K
Cartesian Therapeutics, Inc.
Cartesian announced positive retreatment data for Descartes-08 in 5 myasthenia gravis patients who initially responded to treatment 16.6 months prior. Retreated patients achieved mean MG-ADL reduction of 6.6 points at Month 12 with no new safety signals; Phase 3 AURORA topline results expected Q1 2027.
▲ Likely positive
· significance 62 · 8-K Agent
SCHEDULE 13D
MoneyHero Ltd
Jonathan Honig, beneficial owner of approximately 9.0% of MoneyHero Limited's Class A Ordinary Shares, issued an open letter on September 29, 2026, urging the Board to immediately retain an independent financial advisor and initiate a strategic review to explore a sale. Honig cited leadership uncertainty (CEO vacancy since April 2026), declining revenue (US$80.7M in FY2023 to US$73.4M in FY2025), stock price collapse of 88% since October 2023 IPO, and lack of insider share purchases. He asserts the company is worth at least US$1.50 per share in a transaction versus the current US$0.675 closing price.
▼ Likely negative
· significance 62 · Ownership Agent
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.